Document Detail

Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.
MedLine Citation:
PMID:  16810279     Owner:  NLM     Status:  MEDLINE    
The present study was performed to compare the long-term effects of 24-h ambulatory blood pressure (BP) control with amlodipine versus valsartan on vascular damage in untreated hypertensive patients. Amlodipine and valsartan have benefits on cardiovascular mortality and morbidity in hypertensive patients. Although ambulatory BP is associated with severity of target-organ damage in hypertensive patients, beneficial effects of ambulatory BP control with amlodipine versus valsartan on vascular damage have not been compared. Pulse wave velocity (PWV), intima-media thickness (IMT) of the carotid arteries, urinary albumin excretion (UAE) and 24-h ambulatory BP were determined in 100 untreated hypertensive patients before and 12 months after the start of antihypertensive therapy with amlodipine or valsartan. Amlodipine and valsartan decreased ambulatory BP similarly, but the variability of 24-h and daytime ambulatory systolic BP was significantly reduced by amlodipine but not by valsartan. The reduced variability of ambulatory systolic BP caused by amlodipine significantly contributed to the improvement of PWV, although both drugs decreased PWV similarly. Carotid IMT was unaffected by treatment with either drug. Valsartan significantly decreased UAE independently of its depressor effect, but amlodipine had no effect on UAE. These results suggest that the 24-h control of ambulatory BP with amlodipine had functionally improved the stiffened arteries of hypertensive patients by the end of 12 months of treatment, in part through reducing BP variability, whereas ambulatory BP control with valsartan decreased the arterial stiffness to the same degree as amlodipine without affecting BP variability maybe through some pleiotropic effects.
A Ichihara; Y Kaneshiro; T Takemitsu; M Sakoda
Related Documents :
20021529 - Nebivolol in high-risk, obese african americans with stage 1 hypertension: effects on b...
7755939 - Effects of intensified blood-pressure reduction on renal function and albumin excretion...
19000959 - Impact of patient-general practitioner short-messages-based interaction on the control ...
20528639 - Challenging hypertension: how to diagnose and treat resistant hypertension in daily cli...
12022239 - Aldosterone synthase (cyp11b2) -344 c/t polymorphism is related to antihypertensive res...
9989539 - Prognosis of diastolic and systolic orthostatic hypotension in older persons.
15522049 - Determinants of hypertension and left ventricular function in end stage renal failure: ...
1218169 - Cardiovascular changes in labour associated with extradural analgesia using bupivacaine.
9814339 - Pressure ulcers: causes, risk factors, assessment, and intervention.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2006-06-29
Journal Detail:
Title:  Journal of human hypertension     Volume:  20     ISSN:  0950-9240     ISO Abbreviation:  J Hum Hypertens     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-21     Completed Date:  2006-12-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  787-94     Citation Subset:  IM    
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amlodipine / administration & dosage*
Antihypertensive Agents / administration & dosage*
Blood Pressure / drug effects*
Blood Pressure Monitoring, Ambulatory
Carotid Arteries / physiopathology*
Endothelium, Vascular / injuries,  physiopathology
Hypertension / drug therapy*,  mortality,  physiopathology,  urine
Middle Aged
Tetrazoles / administration & dosage*
Valine / administration & dosage,  analogs & derivatives*
Vascular Resistance / drug effects
Reg. No./Substance:
0/Antihypertensive Agents; 0/Tetrazoles; 137862-53-4/valsartan; 7004-03-7/Valine; 88150-42-9/Amlodipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A large-scale study on relationship between cerebral blood flow velocity and blood pressure in a nat...
Next Document:  ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7).